| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |